Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Roots

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics|March 29, 2002
Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporterRolf Kaiser, Bruno Müller-Oerlinghausen, Diana Filler, et al.
Clinical Pharmacokinetics|March 10, 2004
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteersJulia Kirchheiner, Ingolf Meineke, Göran Müller, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interactionIngrid Mai, Steffen Bauer, Elke S Perloff, et al.
Pharmacogenetics and Genomics|July 12, 2005
Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in plateletsJulia Kirchheiner, Hanns-Benjamin Henckel, Leonora Franke, et al.
British Journal of Clinical Pharmacology|November 4, 2004
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patientsIngrid Mai, Elke S Perloff, Steffen Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patientsPierre-Benoit Tremblay, Rolf Kaiser, Orhan Sezer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 29, 2006
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levelsThomas Gerloff, Melanie Schaefer, Jessica Mwinyi, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patientsSteffen Bauer, Elke Störmer, Andreas Johne, et al.
Genetic Testing|March 1, 2008
An anomalous haplotype distribution of the arrestin domain-containing 4 gene (ARRDC4) haplotypes in CaucasiansBettina Knoll, Mark Goldammer, Agnieszka Wojewoda, et al.
Clinical Drug Investigation|May 31, 2007
Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteersKonstanze Diefenbach, Frank Donath, Agathe Maurer, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics|March 29, 2002
Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporterRolf Kaiser, Bruno Müller-Oerlinghausen, Diana Filler, et al.
Clinical Pharmacokinetics|March 10, 2004
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteersJulia Kirchheiner, Ingolf Meineke, Göran Müller, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interactionIngrid Mai, Steffen Bauer, Elke S Perloff, et al.
Pharmacogenetics and Genomics|July 12, 2005
Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in plateletsJulia Kirchheiner, Hanns-Benjamin Henckel, Leonora Franke, et al.
British Journal of Clinical Pharmacology|November 4, 2004
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patientsIngrid Mai, Elke S Perloff, Steffen Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patientsPierre-Benoit Tremblay, Rolf Kaiser, Orhan Sezer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 29, 2006
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levelsThomas Gerloff, Melanie Schaefer, Jessica Mwinyi, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patientsSteffen Bauer, Elke Störmer, Andreas Johne, et al.
Genetic Testing|March 1, 2008
An anomalous haplotype distribution of the arrestin domain-containing 4 gene (ARRDC4) haplotypes in CaucasiansBettina Knoll, Mark Goldammer, Agnieszka Wojewoda, et al.
Clinical Drug Investigation|May 31, 2007
Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteersKonstanze Diefenbach, Frank Donath, Agathe Maurer, et al.
Pageof 10